Tag: Investigational New Drug Application (IND)
Toothpaste Therapy for Food Allergies Takes Another Step Forward
FDA accepts IND application by Intrommune Therapeutics.
FDA Opens Door for Clinical Development of Aquestive Therapeutics Anaphylaxis Treatment
Emergency epinephrine candidate dissolves in the mouth.
Intrommune’s Food Allergy Toothpaste Therapy to Advance to Clinical Trials
See the interview with the CEO as well as a new video describing the therapy here.
Bryn Pharma Completes Dosing in Pivotal Clinical Trial Designed to Support...
Nasal Spray Product is Disruptive Innovation for People at Risk of Anaphylaxis.
Aimmune to Begin Phase 2 Trials of Egg Allergy OIT Candidate
AR201 for Egg Allergy Phase 2 Initiation Planned for 2019.
ConsortiaTX Awarded Exclusive License for Food Allergy Microbial Therapy
The company is developing therapies for food allergies based on bacteria found in the human gut microbiome.
Company Developing Peanut Immunotherapy Toothpaste Meets with FDA
"INT301 has the potential to be the first allergy immunotherapy treatment that easily integrates into a person’s daily routine."
Intrommune Therapeutics Seeks Crowdfunding for Novel Toothpaste Immunotherapy
The company is developing a therapy called "Oral Mucosal Immunotherapy".
